Yacine Maringer

9PUBLICATIONS
40CO-AUTHORS
Innate immunityApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Pacific Peoples epidemiologyMolecular targetsHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Oct 17, 2023
Immune Surveillance of Acute Myeloid Leukemia Is Mediated by HLA-Presented Antigens on Leukemia Progenitor Cells.

Annika Nelde, Heiko Schuster, Jonas S Heitmann

|Aug 18, 2023
Phase I/II trial of a peptide-based COVID-19 T-cell activator in patients with B-cell deficiency.

Jonas S Heitmann, Claudia Tandler, Maddalena Marconato

|Mar 30, 2023
Elevated SARS-CoV-2-Specific Antibody Levels in Patients with Post-COVID Syndrome.

Christopher Hackenbruch, Yacine Maringer, Christian M Tegeler

|Nov 01, 2022
Durable spike-specific T cell responses after different COVID-19 vaccination regimens are not further enhanced by booster vaccination.

Yacine Maringer, Annika Nelde, Sarah M Schroeder

|Oct 27, 2022
The oncogenic fusion protein DNAJB1-PRKACA can be specifically targeted by peptide-based immunotherapy in fibrolamellar hepatocellular carcinoma.

Jens Bauer, Natalie Köhler, Yacine Maringer

|Oct 14, 2022
Immunopeptidome Diversity in Chronic Lymphocytic Leukemia Identifies Patients with Favorable Disease Outcome.

Maddalena Marconato, Yacine Maringer, Juliane S Walz

Pageof 2

Frequent Collaborators

9 joint publications

Annika Nelde

8 joint publications

Juliane S Walz

6 joint publications

Helmut R Salih

5 joint publications

Jens Bauer